Adverse Reactions (300)

All reported adverse reactions from the FDA FAERS database, sorted by total report count.

#	Reaction	Total Reports	Drugs Involved
1	DRUG INEFFECTIVE	3,105,678	729
2	FATIGUE	2,489,744	719
3	OFF LABEL USE	2,394,039	700
4	NAUSEA	2,239,650	737
5	DIARRHOEA	1,934,049	671
6	PAIN	1,918,498	624
7	HEADACHE	1,711,076	635
8	DYSPNOEA	1,698,664	633
9	VOMITING	1,285,499	647
10	ARTHRALGIA	1,261,559	420
11	DEATH	1,229,019	487
12	DIZZINESS	1,195,774	567
13	RASH	1,119,343	465
14	MALAISE	1,059,312	544
15	ASTHENIA	1,006,089	533
16	PNEUMONIA	988,504	484
17	PYREXIA	928,962	462
18	FALL	817,593	394
19	CONDITION AGGRAVATED	772,824	339
20	WEIGHT DECREASED	595,573	348
21	PAIN IN EXTREMITY	579,664	246
22	PRURITUS	577,023	264
23	RHEUMATOID ARTHRITIS	506,079	57
24	COUGH	492,083	249
25	ANXIETY	464,706	288
26	ACUTE KIDNEY INJURY	437,242	229
27	JOINT SWELLING	410,371	74
28	ALOPECIA	382,570	98
29	INSOMNIA	355,764	225
30	ANAEMIA	352,938	243
31	HYPERTENSION	325,649	176
32	ABDOMINAL DISCOMFORT	323,556	92
33	TOXICITY TO VARIOUS AGENTS	316,148	103
34	WEIGHT INCREASED	312,044	131
35	DRUG INTERACTION	306,585	191
36	DECREASED APPETITE	305,209	203
37	CONSTIPATION	297,014	209
38	DEPRESSION	293,350	187
39	HYPOTENSION	284,097	176
40	INJECTION SITE PAIN	273,830	55
41	HYPERSENSITIVITY	267,050	100
42	ABDOMINAL PAIN	259,848	198
43	DRUG INTOLERANCE	257,785	50
44	CHRONIC KIDNEY DISEASE	256,834	114
45	PRODUCT USE IN UNAPPROVED INDICATION	253,477	155
46	BACK PAIN	244,660	149
47	NASOPHARYNGITIS	243,044	77
48	RENAL FAILURE	239,529	164
49	DRUG HYPERSENSITIVITY	238,910	83
50	NEUTROPENIA	232,239	111
51	INFUSION RELATED REACTION	223,952	52
52	PRODUCT DOSE OMISSION ISSUE	217,061	138
53	BLOOD GLUCOSE INCREASED	207,911	42
54	PERIPHERAL SWELLING	207,800	62
55	SOMNOLENCE	207,716	137
56	OVERDOSE	193,486	63
57	ARTHROPATHY	190,397	29
58	FEBRILE NEUTROPENIA	181,904	85
59	SYSTEMIC LUPUS ERYTHEMATOSUS	177,122	31
60	SWELLING	161,473	31
61	ASTHMA	156,452	43
62	THROMBOCYTOPENIA	155,747	119
63	DISEASE PROGRESSION	153,547	86
64	CONTRAINDICATED PRODUCT ADMINISTERED	153,442	22
65	DRUG DEPENDENCE	152,084	23
66	SYNOVITIS	143,356	24
67	MALIGNANT NEOPLASM PROGRESSION	142,728	70
68	TREATMENT FAILURE	141,929	42
69	CONFUSIONAL STATE	141,629	93
70	PEMPHIGUS	141,455	25
71	FEELING ABNORMAL	136,146	111
72	INFECTION	135,327	70
73	INCORRECT DOSE ADMINISTERED	129,089	45
74	COMPLETED SUICIDE	127,622	44
75	COVID-19	121,258	80
76	GAIT DISTURBANCE	118,888	63
77	PSORIASIS	117,185	14
78	GLOSSODYNIA	112,077	23
79	INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION	108,560	50
80	CHEST PAIN	108,231	65
81	SEPSIS	107,452	106
82	EMOTIONAL DISTRESS	107,209	32
83	ABDOMINAL PAIN UPPER	103,686	88
84	HAND DEFORMITY	102,872	22
85	INTENTIONAL PRODUCT USE ISSUE	99,516	39
86	DRUG ABUSE	99,089	32
87	MYOCARDIAL INFARCTION	98,858	45
88	HEPATIC ENZYME INCREASED	98,144	29
89	URINARY TRACT INFECTION	97,142	89
90	SEIZURE	96,413	29
91	PLATELET COUNT DECREASED	93,404	74
92	INJECTION SITE ERYTHEMA	93,193	18
93	NEUROPATHY PERIPHERAL	92,846	42
94	WHITE BLOOD CELL COUNT DECREASED	92,537	50
95	DRY SKIN	91,107	16
96	GENERAL PHYSICAL HEALTH DETERIORATION	90,010	60
97	ERYTHEMA	88,240	44
98	PRODUCT USE ISSUE	84,135	53
99	TREMOR	84,094	67
100	MULTIPLE SCLEROSIS RELAPSE	78,873	20
101	URTICARIA	75,826	47
102	WRONG TECHNIQUE IN PRODUCT USAGE PROCESS	75,793	29
103	BLOOD PRESSURE INCREASED	75,062	56
104	MUSCULOSKELETAL STIFFNESS	74,299	11
105	WOUND	71,641	16
106	MUSCLE SPASMS	71,365	44
107	SINUSITIS	70,372	35
108	WHEEZING	70,357	31
109	CEREBROVASCULAR ACCIDENT	69,578	39
110	MYALGIA	67,760	40
111	BREAST CANCER	66,293	11
112	PLASMA CELL MYELOMA	65,511	12
113	OEDEMA PERIPHERAL	63,798	42
114	HOSPITALISATION	63,224	41
115	GASTROINTESTINAL HAEMORRHAGE	62,419	13
116	NO ADVERSE EVENT	61,949	38
117	ATRIAL FIBRILLATION	60,976	29
118	DEVICE EXPULSION	59,838	4
119	DEHYDRATION	59,008	64
120	MATERNAL EXPOSURE DURING PREGNANCY	58,610	43
121	DRUG DOSE OMISSION	57,684	33
122	CROHN^S DISEASE	57,622	11
123	ACNE	55,775	5
124	SKIN BURNING SENSATION	55,714	4
125	ACCIDENTAL EXPOSURE TO PRODUCT	53,287	10
126	DEVICE DIFFICULT TO USE	53,153	6
127	FLUSHING	53,076	18
128	HYPOAESTHESIA	53,075	28
129	DRUG WITHDRAWAL SYNDROME	52,958	11
130	MYELOSUPPRESSION	52,642	36
131	DRUG DOSE OMISSION BY DEVICE	51,482	6
132	FOETAL EXPOSURE DURING PREGNANCY	50,394	43
133	BONE DENSITY DECREASED	50,101	13
134	PRODUCT QUALITY ISSUE	46,939	30
135	MULTIPLE SCLEROSIS	46,709	17
136	SUICIDAL IDEATION	46,632	36
137	BLOOD GLUCOSE DECREASED	45,770	17
138	MEMORY IMPAIRMENT	45,766	27
139	PSORIATIC ARTHROPATHY	44,442	11
140	THERAPEUTIC PRODUCT EFFECT DECREASED	44,281	10
141	PANCYTOPENIA	43,145	44
142	SKIN EXFOLIATION	43,013	9
143	DERMATITIS ATOPIC	42,344	5
144	RENAL INJURY	41,994	12
145	INJECTION SITE SWELLING	41,947	12
146	DEVICE ISSUE	39,059	15
147	INJECTION SITE HAEMORRHAGE	38,874	12
148	PULMONARY EMBOLISM	37,495	29
149	BREAST CANCER FEMALE	37,439	6
150	DEPENDENCE	37,403	6
151	CARDIAC FAILURE	36,822	23
152	INJECTION SITE REACTION	36,704	12
153	INJECTION SITE BRUISING	36,412	15
154	HAEMOGLOBIN DECREASED	36,350	32
155	THERAPEUTIC PRODUCT EFFECT INCOMPLETE	35,702	26
156	SUICIDE ATTEMPT	35,594	25
157	CARDIAC FAILURE CONGESTIVE	35,501	21
158	SKIN IRRITATION	35,475	3
159	HYPOGLYCAEMIA	35,444	17
160	HOT FLUSH	35,430	16
161	BALANCE DISORDER	35,211	26
162	INJURY	35,133	13
163	PERICARDITIS	34,810	10
164	MIGRAINE	34,386	23
165	HAEMORRHAGE	34,366	20
166	FLUID RETENTION	33,525	20
167	PARAESTHESIA	31,158	25
168	DEVICE DISLOCATION	31,015	4
169	VISUAL IMPAIRMENT	30,737	26
170	RENAL IMPAIRMENT	30,732	42
171	MUSCULAR WEAKNESS	30,350	21
172	ADVERSE DRUG REACTION	29,945	11
173	MUCOSAL INFLAMMATION	29,397	23
174	GYNAECOMASTIA	29,396	3
175	INTENTIONAL OVERDOSE	29,298	20
176	INJECTION SITE PRURITUS	29,206	9
177	INFLUENZA LIKE ILLNESS	29,173	9
178	DIABETES MELLITUS	29,148	14
179	RESPIRATORY FAILURE	28,953	40
180	SEPTIC SHOCK	28,898	33
181	PRODUCT STORAGE ERROR	28,505	14
182	OSTEONECROSIS	27,880	7
183	COLITIS ULCERATIVE	27,532	6
184	LEUKOPENIA	27,276	23
185	BONE LOSS	26,781	6
186	CHRONIC OBSTRUCTIVE PULMONARY DISEASE	26,774	16
187	CYTOMEGALOVIRUS INFECTION	26,340	17
188	HALLUCINATION	26,084	15
189	CHEST DISCOMFORT	26,012	21
190	STOMATITIS	25,950	21
191	ANHEDONIA	25,659	18
192	BLADDER CANCER	25,484	2
193	DEVICE BREAKAGE	25,472	4
194	ECZEMA	25,363	5
195	OSTEOPOROSIS	25,350	15
196	PROSTATE CANCER	25,279	5
197	DISCOMFORT	24,729	9
198	MULTIPLE FRACTURES	24,648	6
199	CONVULSION	24,488	17
200	NEOPLASM PROGRESSION	24,346	13
201	PRODUCT ADHESION ISSUE	24,329	13
202	SKELETAL INJURY	23,915	6
203	DEEP VEIN THROMBOSIS	23,661	15
204	OXYGEN SATURATION DECREASED	23,575	16
205	INCORRECT ROUTE OF DRUG ADMINISTRATION	23,320	1
206	EPILEPSY	23,296	18
207	GASTROOESOPHAGEAL REFLUX DISEASE	23,276	19
208	TOOTH LOSS	23,034	6
209	CHILLS	22,151	20
210	PULMONARY ARTERIAL HYPERTENSION	22,095	9
211	DYSPNOEA EXERTIONAL	21,957	12
212	THROMBOSIS	21,913	13
213	UNDERDOSE	21,445	14
214	NEUTROPHIL COUNT DECREASED	21,118	22
215	END STAGE RENAL DISEASE	20,405	11
216	EYE IRRITATION	20,199	12
217	PRODUCTIVE COUGH	20,195	18
218	BLOOD CREATININE INCREASED	20,159	23
219	DISEASE RECURRENCE	20,098	1
220	VAGINAL HAEMORRHAGE	19,976	6
221	TARDIVE DYSKINESIA	19,778	7
222	DEVICE LEAKAGE	19,777	7
223	EYE PAIN	19,659	14
224	TYPE 2 DIABETES MELLITUS	19,612	4
225	VISION BLURRED	19,609	22
226	DYSGEUSIA	19,564	12
227	EXTRAPYRAMIDAL DISORDER	19,395	7
228	DEVICE MALFUNCTION	19,203	11
229	LACTIC ACIDOSIS	19,200	6
230	SEDATION	19,075	18
231	GLYCOSYLATED HAEMOGLOBIN INCREASED	18,448	13
232	PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME	18,440	9
233	EPISTAXIS	18,192	14
234	AGGRESSION	18,185	21
235	CYTOKINE RELEASE SYNDROME	18,006	11
236	DRY EYE	17,689	8
237	COLORECTAL CANCER	17,674	1
238	PAIN IN JAW	17,541	8
239	HYPERHIDROSIS	17,237	24
240	COMPLICATION OF DEVICE INSERTION	17,202	3
241	LOWER RESPIRATORY TRACT INFECTION	17,089	8
242	DRUG RESISTANCE	17,037	25
243	MENSTRUATION IRREGULAR	17,017	2
244	CARDIAC ARREST	16,843	24
245	TRANSPLANT REJECTION	16,762	10
246	DYSKINESIA	16,703	16
247	PSYCHOTIC DISORDER	16,638	12
248	RENAL CANCER	16,632	2
249	BONE PAIN	16,629	9
250	PAIN OF SKIN	16,452	3
251	THERAPEUTIC RESPONSE DECREASED	15,905	7
252	WRONG TECHNIQUE IN DEVICE USAGE PROCESS	15,845	10
253	HELICOBACTER INFECTION	15,829	8
254	DUODENAL ULCER PERFORATION	15,558	6
255	AGITATION	15,323	19
256	DRUG WITHDRAWAL SYNDROME NEONATAL	15,246	11
257	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE	15,229	4
258	LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES	15,000	12
259	SICKLE CELL ANAEMIA WITH CRISIS	14,503	3
260	ILLNESS	14,334	22
261	DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	14,156	16
262	TREATMENT NONCOMPLIANCE	14,012	15
263	MOBILITY DECREASED	13,909	8
264	MULTIPLE ORGAN DYSFUNCTION SYNDROME	13,903	24
265	DEVICE USE ERROR	13,854	5
266	ABDOMINAL DISTENSION	13,849	19
267	INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION	13,415	14
268	COMPLICATION OF DEVICE REMOVAL	13,185	2
269	BREAST CANCER METASTATIC	13,090	11
270	DEVICE ADHESION ISSUE	13,047	3
271	EXTRA DOSE ADMINISTERED	12,966	4
272	BRADYCARDIA	12,842	17
273	APPLICATION SITE PRURITUS	12,838	8
274	DYSPEPSIA	12,813	15
275	THERAPY INTERRUPTED	12,752	13
276	PANCREATIC CARCINOMA	12,387	6
277	PRODUCT DOSE OMISSION	12,380	14
278	EXPOSURE VIA SKIN CONTACT	12,368	2
279	INCORRECT DRUG ADMINISTRATION DURATION	12,252	11
280	EYE PRURITUS	12,189	7
281	OSTEOPENIA	11,995	7
282	INTERSTITIAL LUNG DISEASE	11,890	17
283	RECTAL HAEMORRHAGE	11,842	5
284	INCORRECT PRODUCT ADMINISTRATION DURATION	11,754	8
285	FEMUR FRACTURE	11,612	2
286	PANCREATITIS	11,544	8
287	EXPOSURE DURING PREGNANCY	11,469	22
288	OCULAR HYPERAEMIA	11,368	12
289	PROCEDURAL PAIN	11,237	3
290	OSTEONECROSIS OF JAW	11,175	2
291	BRONCHITIS	11,150	10
292	ABNORMAL WEIGHT GAIN	11,111	2
293	DYSTONIA	11,100	8
294	ECONOMIC PROBLEM	11,037	10
295	GENITAL HAEMORRHAGE	11,020	1
296	INTENTIONAL PRODUCT MISUSE	10,995	13
297	ILL-DEFINED DISORDER	10,957	5
298	CONTUSION	10,938	10
299	METASTASES TO BONE	10,884	12
300	DIABETIC KETOACIDOSIS	10,847	6